Arabic Arabic English English French French German German
dark

Ionpath Expands Biopharmaceutical Partnerships Program to Rapidly Deliver Novel Insights Utilizing the Company’s High-Definition Spatial Proteomics Platform

Ionpath, Inc. today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company’s Multiplexed Ion Beam Imaging (MIBI™) technology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Lilly and Lycia Ink $1.6 Billion+ Collaboration and Licensing Deal

Next Post

PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services

Related Posts
Total
0
Share